Feder, S., Wiest, R., Weiss, T. S., Aslanidis, C., Schacherer, D., Krautbauer, S., . . . Buechler, C. (2021). Proprotein convertase subtilisin/kexin type 9 (PCSK9) levels are not associated with severity of liver disease and are inversely related to cholesterol in a cohort of thirty eight patients with liver cirrhosis. Lipids Health Dis.

Feder, Susanne, Reiner Wiest, Thomas S. Weiss, Charalampos Aslanidis, Doris Schacherer, Sabrina Krautbauer, Gerhard Liebisch, and Christa Buechler. "Proprotein Convertase Subtilisin/kexin Type 9 (PCSK9) Levels Are Not Associated With Severity of Liver Disease and Are Inversely Related to Cholesterol in a Cohort of Thirty Eight Patients With Liver Cirrhosis." Lipids Health Dis 2021.

Feder, Susanne, et al. "Proprotein Convertase Subtilisin/kexin Type 9 (PCSK9) Levels Are Not Associated With Severity of Liver Disease and Are Inversely Related to Cholesterol in a Cohort of Thirty Eight Patients With Liver Cirrhosis." Lipids Health Dis 2021.